Related Experiment Video

Updated: Aug 17, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Antibody engineering--a valuable asset in preventing closed environment epidemics

Ted Fjallman1, J Christopher Hall

  • 1Department of Environmental Biology, University of Guelph, Guelph, Canada. tfjallma@uoguelph.ca

Acta Astronautica
|July 14, 2005
PubMed

Insights

Spacecraft harbor microbes that damage equipment and crops. Recombinant antibodies offer a novel solution for integrated pest management in life support systems, enhancing disease resistance.

Area of Science:

  • Microbiology
  • Biotechnology
  • Space Science

Background:

  • Microbial contamination, including bacteria and fungi, is a significant issue on spacecraft (e.g., Mir, Space Shuttle, Skylab, Apollo).
  • These microbes can degrade equipment and harm crops grown in space environments.
  • Key terrestrial fungal pathogens like Phytophthora, Pythium, and Fusarium, responsible for greenhouse epidemics, have been detected in life support system test-beds.

Purpose of the Study:

  • To explore the potential of recombinant antibody technologies for managing microbial contamination in space life support systems.
  • To investigate novel strategies for enhancing the efficacy of existing antifungal countermeasures.
  • To propose methods for developing direct disease resistance in space-grown crops and life support systems.

Main Methods:

  • Utilizing recombinant antibody technologies such as ribosome display and phage display for antibody development.
  • Engineering antibodies against specific toxins or organisms relevant to spacecraft microbial contamination.
  • Exploring in vitro molecular evolution for antibody maturation.
  • Investigating chemical linkage of antibodies to biocides and pathogen trapping in biofilters.
  • Proposing in situ expression of antibody-biocide fusions in plants or microbes.

Main Results:

  • Recombinant antibody technologies enable the development of antibodies against a wide range of targets.
  • Antibodies can be evolved in vitro for enhanced efficacy.
  • Chemical linkage of antibodies to biocides can improve antifungal countermeasure effectiveness.
  • In situ expression of antibody-biocide fusions offers a pathway to direct disease resistance.

Conclusions:

  • Recombinant antibodies present a promising tool for integrated pest management in space life support systems.
  • Antibody-biocide fusions can enhance existing countermeasures and provide novel disease resistance strategies.
  • This approach has the potential to mitigate microbial risks to both equipment and space agriculture.

More Related Videos

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera08:21

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera

Published on: May 23, 2025

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens09:08

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview